<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="3750">Clofibrate</z:chebi> (20 mg day-1 kg-1 body weight) given orally for 2 weeks to 18 subjects with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> reduced the total serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentration from 44.4 (22.1-71.7) mumol/l (median, range) to 15.0 (7.9-28.9) mumol/l, mainly by decreasing the 'indirect' fraction to 34.5% of pretreatment values </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast to treatment with <z:chebi fb="0" ids="8069">phenobarbitone</z:chebi>, <z:chebi fb="0" ids="3750">clofibrate</z:chebi> did not change the ratio of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> mono- to di-conjugates in bile </plain></SENT>
<SENT sid="2" pm="."><plain>The initial plasma disappearance rate of <z:chebi fb="0" ids="31696">indocyanine green</z:chebi> and of bromosulphophthalein did not show consistent changes during <z:chebi fb="0" ids="3750">clofibrate</z:chebi> treatment but the 'apparent' maximal biliary secretion capacity of bromosulphophthalein (Tm) decreased in most of the patients studied, whereas the relative storage capacity (S) tended to increase </plain></SENT>
<SENT sid="3" pm="."><plain>As expected, the cholesterol saturation of bile increased in <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="4" pm="."><plain>These results suggest that <z:chebi fb="0" ids="3750">clofibrate</z:chebi> increases mainly the glucuronidation of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, promoting as such the overall hepatic transport in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>However, it decreases the maximal biliary secretion of bromosulphophthalein, possibly by an increased hepatic retention </plain></SENT>
<SENT sid="6" pm="."><plain>These phenomena might be linked to the augmented content of Z protein in the liver </plain></SENT>
</text></document>